Isotretinoin Syndrome is a rare condition that can occur in infants whose mothers took isotretinoin, a medication used to treat severe acne, during pregnancy. It is also known as Accutane embryopathy or retinoic acid embryopathy. Isotretinoin is a powerful drug that belongs to the retinoid class, and it is known to have teratogenic effects, meaning it can cause birth defects.
The syndrome is characterized by a range of physical and developmental abnormalities in affected infants. These can include facial dysmorphia (such as small ears, cleft palate, and small eyes), cardiovascular defects, central nervous system abnormalities, and growth retardation. The severity of the syndrome can vary from mild to severe.
Due to the potential risks associated with isotretinoin, it is crucial for women of childbearing age to use effective contraception while taking the medication. Additionally, healthcare providers should carefully monitor patients and provide appropriate counseling to prevent pregnancy during isotretinoin treatment.
It is important to note that this information is not intended to replace medical advice. If you have concerns about isotretinoin or its potential effects, please consult with a healthcare professional.